search
Back to results

The Australian Placental Transfusion Study (APTS): Should Very Pre Term Babies Receive a Placental Blood Transfusion at Birth Via Deferring Cord Clamping Versus Standard Cord Clamping Procedures? (APTS)

Primary Purpose

Preterm Birth

Status
Completed
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
Deferred cord clamping
Sponsored by
University of Sydney
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Preterm Birth

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

Women who have a reasonable chance of delivering less than 30 weeks of gestation. Informed consent has been received from the parent or guardian.

Exclusion Criteria:

No indication or contraindication to placental transfusion, in the view of mother or baby.

Sites / Locations

  • Baylor College of Medicine
  • University of Vermont Medical Centre
  • Canberra Hospital
  • John Hunter Hospital
  • Liverpool Hospital
  • Royal Prince Alfred Hospital
  • Royal North Shore Hospital
  • Royal Hospital for Women
  • Nepean Hospital
  • Mater Mother's Hospital
  • Royal Brisbane and Women's Hospital
  • Townsville Hospital
  • Flinders Medical Centre
  • Monash Medical Centre
  • Mercy Hospital for Women
  • King Edward Memorial Hospital
  • IWK Health Center
  • Hôpital Antoine-Béclère
  • Auckland Hospital
  • Christchurch Hospital
  • Dunedin Hospital
  • Waikato Hospital
  • Wellington Hospital
  • Aga Khan University Hospital
  • Royal Jubilee Maternity Hospital
  • Craigavon Area Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Early cord clamping (Control Arm)

Deferred cord clamping

Arm Description

Immediate cord clamping (< 10 seconds after birth). The cord is clamped 6 cm from the umbilicus within ten seconds of delivery of the baby.

Deferred cord clamping. Investigator/Research personnel holds the baby as low as possible below the level of the introitus or placenta for 60 seconds and not to exceed 80 seconds, then clamps the cord about 6 cm from the umbilicus.

Outcomes

Primary Outcome Measures

Death and/or major morbidity at 36 weeks post menstrual age
Composite death and/or major morbidity at 36 completed weeks post menstrual age. Morbidity is defined by one or more of the following: brain injury on ultrasound, severe retinopathy, necrotising enterocolitis, late onset sepsis.

Secondary Outcome Measures

Incidence of death
The death component of the composite primary outcome
Incidence of major morbidity
Major morbidity (incidence of one or more of brain injury on ultrasound, severe retinopathy, necrotising enterocolitis or late onset sepsis).
Incidence of death or major disability
Death or major disability (for example cerebral palsy with inability to walk; blindness; deafness; major problems with language or speech; ASQ score indicative of developmental delay)
Incidence of death or brain injury on ultrasound
Death or brain injury on ultrasound
Major disability defined as cerebral palsy with an inability to walk unassisted, severe visual loss, deafness, major problems with language or speech, or a score indicative of developmental delay on Ages and Stages Questionnaire.
Brain injury on ultrasound
IVH (all grades) seen on ultrasound
IVH (Grades 3 & 4) seen on ultrasound
IVH (Grade 4) seen on ultrasound
Severe retinopathy warranting treatment or Stage 4 retinopathy according to the Australian and New Zealand Neonatal Network (ANZNN) definitions
Necrotizing enterocolitis with the following signs: at least 1 systemic sign, profile consistent with definite NEC, warranted treatment for NEC.
Patent ductus arteriosis requiring treatment (documented in medical records)
Chronic lung disease, defined as receiving supplemental oxygen or any form of assisted ventilation at 36 completed weeks post menstrual age for 4 consecutive hours in a 24 hour period
Late onset sepsis, defined as a clinical picture consistent with sepsis, and either a positive culture of blood and/or CSF, or a positive urine culture by sterile collection, and at least 5 days of antibiotic treatment.
Death up to 3 years corrected age

Full Information

First Posted
January 8, 2015
Last Updated
November 4, 2020
Sponsor
University of Sydney
Collaborators
National Health and Medical Research Council, Australia, Baylor College of Medicine
search

1. Study Identification

Unique Protocol Identification Number
NCT02606058
Brief Title
The Australian Placental Transfusion Study (APTS): Should Very Pre Term Babies Receive a Placental Blood Transfusion at Birth Via Deferring Cord Clamping Versus Standard Cord Clamping Procedures?
Acronym
APTS
Official Title
A Randomised Two Arm Open Label Controlled Trial Comparing Standard Immediate Cord Clamping Versus Deferring Cord Clamping for 60 Seconds or More in Babies Born Less Than 30 Weeks of Gestation to Determine Which Cord Clamping Method Results in Improved Survival and Less Disability.
Study Type
Interventional

2. Study Status

Record Verification Date
November 2020
Overall Recruitment Status
Completed
Study Start Date
September 2010 (Actual)
Primary Completion Date
April 2017 (Actual)
Study Completion Date
September 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Sydney
Collaborators
National Health and Medical Research Council, Australia, Baylor College of Medicine

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
To establish if placental transfusion, using deferred cord clamping for 60 seconds or more while holding the baby at or below the level of the placenta, will improve survival without disability compared with standard early cord clamping in preterm babies less than 30 weeks of gestation.
Detailed Description
Most preterm babies have the umbilical cord clamped within 10 seconds of birth. Placental transfusion is a simple way of giving the baby extra blood at birth by delaying the clamping of the umbilical cord by 60 seconds or more. There is promising evidence from randomised trials that placental transfusion in babies less than 37 weeks of pregnancy may improve their blood pressure, reduce the number of blood transfusions needed and decrease bleeding into the brain, bowel disease and infection. However, we not know if babies born before 30 weeks of pregnancy benefit or if placental transfusion increases or decreases death or childhood disability. Despite this uncertainty more doctors are recommending that all very preterm babies are given a placental transfusion at birth. It is important to find out if placental transfusion does more good than harm, before it becomes even more widely used. The Australian Placental Transfusion Study will enrol at least 1600 women who will give birth to babies born less than 30 weeks of gestation. These participants will be randomly assigned to either standard treatment where the umbilical cord is clamped within 10 seconds of birth or a second method where the umbilical cord will be clamped after waiting for 60 seconds or more at birth while the baby is being held below the level of the placenta. The main research question is whether placental transfusion reduces death and disability when the baby is discharged from hospital and into childhood.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Preterm Birth

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
1637 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Early cord clamping (Control Arm)
Arm Type
No Intervention
Arm Description
Immediate cord clamping (< 10 seconds after birth). The cord is clamped 6 cm from the umbilicus within ten seconds of delivery of the baby.
Arm Title
Deferred cord clamping
Arm Type
Experimental
Arm Description
Deferred cord clamping. Investigator/Research personnel holds the baby as low as possible below the level of the introitus or placenta for 60 seconds and not to exceed 80 seconds, then clamps the cord about 6 cm from the umbilicus.
Intervention Type
Procedure
Intervention Name(s)
Deferred cord clamping
Intervention Description
Deferred cord clamping (for 60 seconds or more with the baby held below or at the level of the placenta)
Primary Outcome Measure Information:
Title
Death and/or major morbidity at 36 weeks post menstrual age
Description
Composite death and/or major morbidity at 36 completed weeks post menstrual age. Morbidity is defined by one or more of the following: brain injury on ultrasound, severe retinopathy, necrotising enterocolitis, late onset sepsis.
Time Frame
36 weeks post menstrual age
Secondary Outcome Measure Information:
Title
Incidence of death
Description
The death component of the composite primary outcome
Time Frame
36 completed weeks post menstrual age
Title
Incidence of major morbidity
Description
Major morbidity (incidence of one or more of brain injury on ultrasound, severe retinopathy, necrotising enterocolitis or late onset sepsis).
Time Frame
36 completed weeks post menstrual age
Title
Incidence of death or major disability
Description
Death or major disability (for example cerebral palsy with inability to walk; blindness; deafness; major problems with language or speech; ASQ score indicative of developmental delay)
Time Frame
Up to 3 years corrected age
Title
Incidence of death or brain injury on ultrasound
Description
Death or brain injury on ultrasound
Time Frame
36 completed weeks post menstrual age
Title
Major disability defined as cerebral palsy with an inability to walk unassisted, severe visual loss, deafness, major problems with language or speech, or a score indicative of developmental delay on Ages and Stages Questionnaire.
Time Frame
Up to 3 years corrected age
Title
Brain injury on ultrasound
Time Frame
36 completed weeks post menstrual age
Title
IVH (all grades) seen on ultrasound
Time Frame
36 completed weeks post menstrual age
Title
IVH (Grades 3 & 4) seen on ultrasound
Time Frame
36 completed weeks post menstrual age
Title
IVH (Grade 4) seen on ultrasound
Time Frame
36 completed weeks post menstrual age
Title
Severe retinopathy warranting treatment or Stage 4 retinopathy according to the Australian and New Zealand Neonatal Network (ANZNN) definitions
Time Frame
36 completed weeks post menstrual age
Title
Necrotizing enterocolitis with the following signs: at least 1 systemic sign, profile consistent with definite NEC, warranted treatment for NEC.
Time Frame
36 completed weeks post menstrual age
Title
Patent ductus arteriosis requiring treatment (documented in medical records)
Time Frame
36 completed weeks post menstrual age
Title
Chronic lung disease, defined as receiving supplemental oxygen or any form of assisted ventilation at 36 completed weeks post menstrual age for 4 consecutive hours in a 24 hour period
Time Frame
36 completed weeks post menstrual age
Title
Late onset sepsis, defined as a clinical picture consistent with sepsis, and either a positive culture of blood and/or CSF, or a positive urine culture by sterile collection, and at least 5 days of antibiotic treatment.
Time Frame
36 completed weeks post menstrual age
Title
Death up to 3 years corrected age
Time Frame
Up to 3 years corrected age

10. Eligibility

Sex
Female
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Women who have a reasonable chance of delivering less than 30 weeks of gestation. Informed consent has been received from the parent or guardian. Exclusion Criteria: No indication or contraindication to placental transfusion, in the view of mother or baby.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
William T Mordi, MD
Organizational Affiliation
University of Sydney
Official's Role
Principal Investigator
Facility Information:
Facility Name
Baylor College of Medicine
City
Houston
State/Province
Texas
ZIP/Postal Code
77030
Country
United States
Facility Name
University of Vermont Medical Centre
City
Burlington
State/Province
Vermont
ZIP/Postal Code
05401
Country
United States
Facility Name
Canberra Hospital
City
Canberra
State/Province
Australian Capital Territory
ZIP/Postal Code
2605
Country
Australia
Facility Name
John Hunter Hospital
City
Newcastle
State/Province
New South Wales
ZIP/Postal Code
2305
Country
Australia
Facility Name
Liverpool Hospital
City
Sydney
State/Province
New South Wales
ZIP/Postal Code
2031
Country
Australia
Facility Name
Royal Prince Alfred Hospital
City
Sydney
State/Province
New South Wales
ZIP/Postal Code
2050
Country
Australia
Facility Name
Royal North Shore Hospital
City
Sydney
State/Province
New South Wales
ZIP/Postal Code
2065
Country
Australia
Facility Name
Royal Hospital for Women
City
Sydney
State/Province
New South Wales
ZIP/Postal Code
2170
Country
Australia
Facility Name
Nepean Hospital
City
Sydney
State/Province
New South Wales
ZIP/Postal Code
2747
Country
Australia
Facility Name
Mater Mother's Hospital
City
Brisbane
State/Province
Queensland
ZIP/Postal Code
4029
Country
Australia
Facility Name
Royal Brisbane and Women's Hospital
City
Brisbane
State/Province
Queensland
ZIP/Postal Code
4101
Country
Australia
Facility Name
Townsville Hospital
City
Townsville
State/Province
Queensland
ZIP/Postal Code
4814
Country
Australia
Facility Name
Flinders Medical Centre
City
Adelaide
State/Province
South Australia
ZIP/Postal Code
5042
Country
Australia
Facility Name
Monash Medical Centre
City
Melbourne
State/Province
Victoria
ZIP/Postal Code
3084
Country
Australia
Facility Name
Mercy Hospital for Women
City
Melbourne
State/Province
Victoria
ZIP/Postal Code
3168
Country
Australia
Facility Name
King Edward Memorial Hospital
City
Perth
State/Province
Western Australia
ZIP/Postal Code
6008
Country
Australia
Facility Name
IWK Health Center
City
Halifax
State/Province
Nova Scotia
ZIP/Postal Code
B3K6BA
Country
Canada
Facility Name
Hôpital Antoine-Béclère
City
Clamart
ZIP/Postal Code
92140
Country
France
Facility Name
Auckland Hospital
City
Auckland
ZIP/Postal Code
1023
Country
New Zealand
Facility Name
Christchurch Hospital
City
Christchurch
ZIP/Postal Code
4710
Country
New Zealand
Facility Name
Dunedin Hospital
City
Dunedin
ZIP/Postal Code
9016
Country
New Zealand
Facility Name
Waikato Hospital
City
Hamilton
ZIP/Postal Code
3204
Country
New Zealand
Facility Name
Wellington Hospital
City
Wellington
ZIP/Postal Code
6021
Country
New Zealand
Facility Name
Aga Khan University Hospital
City
Karachi
ZIP/Postal Code
74800
Country
Pakistan
Facility Name
Royal Jubilee Maternity Hospital
City
Belfast
State/Province
Northern Ireland
ZIP/Postal Code
BT12 6BA
Country
United Kingdom
Facility Name
Craigavon Area Hospital
City
Craigavon
State/Province
Northern Ireland
ZIP/Postal Code
BT63 5QQ
Country
United Kingdom

12. IPD Sharing Statement

Learn more about this trial

The Australian Placental Transfusion Study (APTS): Should Very Pre Term Babies Receive a Placental Blood Transfusion at Birth Via Deferring Cord Clamping Versus Standard Cord Clamping Procedures?

We'll reach out to this number within 24 hrs